These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 11855845
1. Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells. Schmitz U, Thömmes K, Beier I, Vetter H. Biochem Biophys Res Commun; 2002 Mar 01; 291(3):687-91. PubMed ID: 11855845 [Abstract] [Full Text] [Related]
3. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells. Goppelt-Struebe M, Fickel S, Reiser CO. Biochem J; 2000 Jan 15; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497 [Abstract] [Full Text] [Related]
4. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies. He H, Hirokawa Y, Levitzki A, Maruta H. Cancer J; 2000 Jan 15; 6(4):243-8. PubMed ID: 11038144 [Abstract] [Full Text] [Related]
5. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells. Chen KC, Zhou Y, Zhang W, Lou MF. Mol Vis; 2007 Mar 14; 13():374-87. PubMed ID: 17392688 [Abstract] [Full Text] [Related]
6. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL. Can J Physiol Pharmacol; 2003 Feb 14; 81(2):159-67. PubMed ID: 12710530 [Abstract] [Full Text] [Related]
7. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Shah BH, Olivares-Reyes JA, Catt KJ. Mol Pharmacol; 2005 Jan 14; 67(1):184-94. PubMed ID: 15465928 [Abstract] [Full Text] [Related]
8. The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration. Toumaniantz G, Ferland-McCollough D, Cario-Toumaniantz C, Pacaud P, Loirand G. Cardiovasc Res; 2010 Apr 01; 86(1):131-40. PubMed ID: 19969623 [Abstract] [Full Text] [Related]
9. Epidermal growth factor stimulates Rac1 and p21-activated kinase in vascular smooth muscle cells. Beier I, Düsing R, Vetter H, Schmitz U. Atherosclerosis; 2008 Jan 01; 196(1):92-97. PubMed ID: 17350025 [Abstract] [Full Text] [Related]
10. Pp60c-src mediates ERK activation/nuclear localization and PAI-1 gene expression in response to cellular deformation. Samarakoon R, Higgins PJ. J Cell Physiol; 2003 Jun 01; 195(3):411-20. PubMed ID: 12704650 [Abstract] [Full Text] [Related]
11. Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation. He H, Hirokawa Y, Manser E, Lim L, Levitzki A, Maruta H. Cancer J; 2001 Jun 01; 7(3):191-202. PubMed ID: 11419027 [Abstract] [Full Text] [Related]
12. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Weber DS, Taniyama Y, Rocic P, Seshiah PN, Dechert MA, Gerthoffer WT, Griendling KK. Circ Res; 2004 May 14; 94(9):1219-26. PubMed ID: 15059930 [Abstract] [Full Text] [Related]
13. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced. Obara Y, Okano Y, Ono S, Yamauchi A, Hoshino T, Kurose H, Nakahata N. Cell Signal; 2008 Jul 14; 20(7):1275-83. PubMed ID: 18407464 [Abstract] [Full Text] [Related]
14. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation. Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T. Mol Pharmacol; 2004 Apr 14; 65(4):832-41. PubMed ID: 15044612 [Abstract] [Full Text] [Related]
15. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Meng D, Shi X, Jiang BH, Fang J. Free Radic Biol Med; 2007 Jun 01; 42(11):1651-60. PubMed ID: 17462533 [Abstract] [Full Text] [Related]
16. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM. Arterioscler Thromb Vasc Biol; 2008 Aug 01; 28(8):1511-8. PubMed ID: 18467645 [Abstract] [Full Text] [Related]
17. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. Touyz RM, Yao G. J Cell Physiol; 2003 Dec 01; 197(3):326-35. PubMed ID: 14566962 [Abstract] [Full Text] [Related]
18. Lysophosphatidic acid receptor signaling in mammalian retinal pigment epithelial cells. Thoreson WB, Ryan JS, Shi C, Kelly ME, Bryson EJ, Toews ML, Ediger TL, Chacko DM. Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2450-61. PubMed ID: 12091450 [Abstract] [Full Text] [Related]
19. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells. Jung ID, Lee J, Lee KB, Park CG, Kim YK, Seo DW, Park D, Lee HW, Han JW, Lee HY. Eur J Biochem; 2004 Apr 01; 271(8):1557-65. PubMed ID: 15066181 [Abstract] [Full Text] [Related]
20. Sphingosine 1-phosphate induces cyclooxygenase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells. Nodai A, Machida T, Izumi S, Hamaya Y, Kohno T, Igarashi Y, Iizuka K, Minami M, Hirafuji M. Life Sci; 2007 Apr 17; 80(19):1768-76. PubMed ID: 17382352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]